TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$11.1M 0.39%
306,433
77
$10.9M 0.38%
193,201
78
$10.7M 0.37%
1,041,845
79
$10.5M 0.37%
258,672
+73,893
80
$10.2M 0.36%
208,108
81
$10.2M 0.36%
132,886
+58,700
82
$9.64M 0.34%
63,513
83
$9.37M 0.33%
405,626
84
$9.35M 0.33%
56,521
85
$8.97M 0.32%
411,743
86
$8.94M 0.31%
144,447
87
$8.93M 0.31%
273,463
+214,124
88
$8.87M 0.31%
510,660
89
$8.85M 0.31%
246,089
-495,207
90
$8.82M 0.31%
495,733
91
$8.66M 0.3%
85,236
+43,409
92
$8.54M 0.3%
76,585
+65,062
93
$8.46M 0.3%
39,769
-2,900
94
$8.41M 0.3%
63,502
+48,352
95
$8.11M 0.29%
93,257
-59,348
96
$8.11M 0.28%
456,296
+157,826
97
$7.31M 0.26%
28,280
98
$7.21M 0.25%
7,771
99
$7.2M 0.25%
+266,023
100
$7.09M 0.25%
182,293
2 3
4
5 6